SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 262.85 |
| Enterprise Value ($M) | 211.60 |
| Book Value ($M) | -148.38 |
| Book Value / Share | -7.07 |
| Price / Book | -1.77 |
| NCAV ($M) | -349.88 |
| NCAV / Share | -16.67 |
| Price / NCAV | -0.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.44 |
| Current Ratio | 0.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 112.42 |
| Assets | 313.91 |
| Liabilities | 462.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 156.31 |
| Operating Income | -160.10 |
| Net Income | -257.44 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -224.20 |
| Cash from Investing | 3.40 |
| Cash from Financing | 119.87 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Point72 Asset Management, L.P. | 6.80 | 2,539,747.26 | |
| 13G/A | Deep Track Capital, LP | 8.31 | 17.40 | |
| 13G/A | Vanguard Group Inc | 7.93 | 24.65 | |
| 13G/A | Artal International S.C.A. | 4.10 | 0.00 | |
| 13G/A | BlackRock Inc. | 8.50 | 37.76 | |
| 13G/A | State Street Corp | 2.28 | -61.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 172,787 | 596,595 | 28.96 | |
| 182,982 | 386,013 | 47.40 | |
| 196,345 | 238,395 | 82.36 | |
| 328,681 | 310,464 | 105.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADTX – Aditxt, Inc. | ADVM – Adverum Biotechnologies, Inc. |
| AEZS – Aeterna Zentaris Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. |